Open Access. Powered by Scholars. Published by Universities.®

Food and Drug Law Commons

Open Access. Powered by Scholars. Published by Universities.®

1076 Full-Text Articles 984 Authors 373490 Downloads 93 Institutions

All Articles in Food and Drug Law

Faceted Search

1076 full-text articles. Page 1 of 30.

Memory And Punishment, O. Carter Snead 2016 Notre Dame Law School

Memory And Punishment, O. Carter Snead

O. Carter Snead

This article is the first scholarly exploration of the implications of neurobiological memory modification for criminal law. Its point of entry is the fertile context of criminal punishment, in which memory plays a crucial role. Specifically, this article will argue that there is a deep relationship between memory and the foundational principles justifying how punishment should be distributed, including retributive justice, deterrence, incapacitation, rehabilitation, moral education, and restorative justice. For all such theoretical justifications, the questions of who and how much to punish are inextricably intertwined with how a crime is remembered - by the offender, by the sentencing authority, and ...


The Current Scientific And Legal Status Of Alternative Methods To The Ld50 Test For Botulinum Neurotoxin Potency Testing, Sarah Adler, Gerd Bicker, Hans Bigalke, Christopher Bishop, Jörg Blümel, Dirk Dressler, Joan Fitzgerald, Frank Gessler, Heide Heuschen, Birgit Kegel, Andreas Luch, Catherine Milne, Andrew Pickett, Heidemarie Ratsch, Irmela Ruhdel, Dorothea Sesardic, Martin Stephens, Gerhard Stiens, Peter D. Thornton, René Thürmer, Martin Vey, Horst Spielmann, Barbara Grune, Manfred Liebsch 2016 Centre for Documentation and Evaluation of Alternatives to Animal Experiments (ZEBET)

The Current Scientific And Legal Status Of Alternative Methods To The Ld50 Test For Botulinum Neurotoxin Potency Testing, Sarah Adler, Gerd Bicker, Hans Bigalke, Christopher Bishop, Jörg Blümel, Dirk Dressler, Joan Fitzgerald, Frank Gessler, Heide Heuschen, Birgit Kegel, Andreas Luch, Catherine Milne, Andrew Pickett, Heidemarie Ratsch, Irmela Ruhdel, Dorothea Sesardic, Martin Stephens, Gerhard Stiens, Peter D. Thornton, René Thürmer, Martin Vey, Horst Spielmann, Barbara Grune, Manfred Liebsch

Martin Stephens, Ph.D.

The Expert Meeting on alternative methods for Botulinum neurotoxin (BoNT) potency testing was held at the BfR as the result of a decree from the German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), after it was informed by German state authorities about an increase in animal numbers being used in the LD50 potency test in mice for the purposes of BoNT potency testing. Ethical concerns have been raised in both Europe and the United States about the animal suffering involved in this type of testing, especially in the context of BoNT’s aesthetic applications. There had been increased ...


The Administrative State And The Common Law: Regulatory Substitutes Or Complements?, Catherine M. Sharkey 2016 NYU School of Law

The Administrative State And The Common Law: Regulatory Substitutes Or Complements?, Catherine M. Sharkey

New York University Public Law and Legal Theory Working Papers

The modern administrative state looms larger than ever, and grows at an ever-accelerating pace. Not everyone is pleased with these developments. Four such individuals — Chief Justice Roberts, Justices Thomas, Alito, and the late Justice Scalia — have expressed their displeasure, indeed their alarm, with consistency, clarity, and vigor. They warn that the rise of administrative agencies, and the attendant ascendance of doctrines of mandatory judicial deference to agency interpretations of federal law, signals no less than the end of our government’s separation-of-powers structure, and our right to live our lives without fear of bureaucratic encroachment at every turn. Their opinions ...


Is Regulation (Ec) No 1924/2006 On Nutrition And Health Claims Applied To Commercial Communications Addressed Exclusively To The Professional Sector (B2b)?, Luis González Vaqué 2016 Asociación Iberoamericana para el Dereho Alimentario

Is Regulation (Ec) No 1924/2006 On Nutrition And Health Claims Applied To Commercial Communications Addressed Exclusively To The Professional Sector (B2b)?, Luis González Vaqué

Luis González Vaqué

See more at: http://www.blmedien.de/data/emags/blmedien/eFOOD-Lab_International_02_2016/#/22/


Litigating Medical Device Premarket Classification Decisions For Small Businesses: Have The Courts Given The Fda Too Much Deference? The Case For Taking The Focus Off Of Efficacy, Stephanie P. Fekete 2016 The Catholic University of America, Columbus School of Law

Litigating Medical Device Premarket Classification Decisions For Small Businesses: Have The Courts Given The Fda Too Much Deference? The Case For Taking The Focus Off Of Efficacy, Stephanie P. Fekete

Catholic University Law Review

The manufacturing of innovative medical devices is important for the continued success and growth of the U.S. health care system and economy. The medical device industry is almost exclusively comprised of small businesses. The U.S. Food and Drug Administration (FDA) regulates the medical device industry and employs a rigorous approval process to determine when products may enter the market. While the FDA’s goal is to authorize the sale of innovative devices that are safe for patient use, device manufacturers argue that the process to obtain FDA approval is unnecessarily expensive, burdensome, and has systemic problems. As a ...


International Fisheries Regulation, John P. Rivers 2016 University of Georgia School of Law

International Fisheries Regulation, John P. Rivers

Georgia Journal of International & Comparative Law

No abstract provided.


Decline Of Dosage Regimen Patents In Light Of Emerging Next-Generation Dna Sequencing Technology And Possible Strategic Responses, Na An 2016 University of Minnesota - Twin Cities

Decline Of Dosage Regimen Patents In Light Of Emerging Next-Generation Dna Sequencing Technology And Possible Strategic Responses, Na An

Minnesota Journal of Law, Science & Technology

No abstract provided.


3d-Printed Food, Jasper L. Tran 2016 George Mason University

3d-Printed Food, Jasper L. Tran

Minnesota Journal of Law, Science & Technology

No abstract provided.


Human Papillomavirus Vaccine Legislation: Are We Oversexualizing Our Youth?, Darryn Cathryn Beckstrom 2016 University of St. Thomas, Minnesota

Human Papillomavirus Vaccine Legislation: Are We Oversexualizing Our Youth?, Darryn Cathryn Beckstrom

University of St. Thomas Journal of Law and Public Policy

No abstract provided.


Quando La Legislazione Può Essere Un Ostacolo Alla Libera Circolazione Di Prodotti Alimentari: Il Caso Del "Semaforo Nutrizionale", Luis González Vaqué 2016 Asociación Iberoamericana para el Dereho Alimentario

Quando La Legislazione Può Essere Un Ostacolo Alla Libera Circolazione Di Prodotti Alimentari: Il Caso Del "Semaforo Nutrizionale", Luis González Vaqué

Luis González Vaqué

È stato scritto molto sul criticato (e criticabile) Regolamento (UE) n. 1169/2011 relativo alla fornitura di informazioni sugli alimenti ai consumatori. ‘Brevitatis causae’, nel presente articolo ci occuperemo in particolare delle disposizioni relative all'etichettatura nutrizionale, non applicabili subito dopo l'entrata in vigore di tale Regolamento; si tratta di un insieme di regole ambigue e confuse, la cui applicazione può supporre un reale e potenziale ostacolo alla libera circolazione dei prodotti alimentari all'interno dell'Unione Europea (UE), vale a dire, tutto il contrario di quello che dovrebbe proporsi come obiettivo…


Pharmaceutical Lemons: Innovation And Regulation In The Drug Industry, Ariel Katz 2016 University of Toronto

Pharmaceutical Lemons: Innovation And Regulation In The Drug Industry, Ariel Katz

Ariel Katz

Before a new drug can be marketed, the Food and Drug Administration must be satisfied that it is safe and effective. According to conventional wisdom, the cost and delay involved in this process diminish the incentives to invest in the development of new drugs. Accordingly, several reforms aimed at restoring such incentives have been implemented or advocated. This Article challenges the central argument that drug regulation and drug innovation are necessarily at odds with one another. Although intuitively appealing, the argument that drug regulation negatively affects the incentives to innovate does not fully capture the role that regulation plays in ...


Pharmaceutical Lemons: Innovation And Regulation In The Drug Industry, Ariel Katz 2016 University of Toronto

Pharmaceutical Lemons: Innovation And Regulation In The Drug Industry, Ariel Katz

Ariel Katz

Before a new drug can be marketed, the Food and Drug Administration must be satisfied that it is safe and effective. According to conventional wisdom, the cost and delay involved in this process diminish the incentives to invest in the development of new drugs. Accordingly, several reforms aimed at restoring such incentives have been implemented or advocated. This Article challenges the central argument that drug regulation and drug innovation are necessarily at odds with one another. Although intuitively appealing, the argument that drug regulation negatively affects the incentives to innovate does not fully capture the role that regulation plays in ...


The Negative Effects Of Cumulative Abortion Regulations: Why The 5th Circuit Was Wrong In Upholding Regulations On Medication Abortions (Planned Parenthood Of Greater Texas Surgical Health Services V. Abbott), Benjamin A. Hooper 2016 University of Cincinnati Law Review

The Negative Effects Of Cumulative Abortion Regulations: Why The 5th Circuit Was Wrong In Upholding Regulations On Medication Abortions (Planned Parenthood Of Greater Texas Surgical Health Services V. Abbott), Benjamin A. Hooper

University of Cincinnati Law Review

No abstract provided.


Qu’Y A-T-Il De Nouveau Dans Le Règlement (Ue) 2015/2283 Relatif Aux Nouveaux Aliments ?, Luis González Vaqué 2016 Asociación Iberoamericana para el Dereho Alimentario

Qu’Y A-T-Il De Nouveau Dans Le Règlement (Ue) 2015/2283 Relatif Aux Nouveaux Aliments ?, Luis González Vaqué

Luis González Vaqué

 
SOMMAIRE:
 
I. Introduction
II. Le règlement (UE) 2015/2283
A. Objet et finalité
B. Champ d'application
C. Définitions
D. Procédures (détermination du statut de nouvel aliment et autorisation)
E. Règles spécifiques applicables aux aliments traditionnels en provenance de pays tiers
F. La « liste de l'Union » et les conditions exigées pour l’inscription d’un nouvel aliment
G. Protection des données
H. Sanctions
I. Autres dispositions
III. Conclusions
A. Un règlement incomplet/imparfait ?
B. Du passé au futur (en passant par le présent)
 


Getting A Handle On Growler Laws, Adam Star 2016 Seattle University School of Law

Getting A Handle On Growler Laws, Adam Star

Seattle University Law Review

This Note will begin with a brief general history of growlers in the United States and the benefits they provide to consumers, retailers, and small craft brewers. Part II will provide an overview of national alcohol distribution regulation and how the present growler law exists within this larger framework. To complete the necessary background information, Part III will provide context to the competitive landscape by way of an examination of the craft beer industry’s explosive growth. The substantive portion of the Note will follow in Part IV, beginning with an outline of the various key types of growler restrictions ...


The Impact Of International Agreements On European Union Food Law, Luis González Vaqué, Isabel Segura Roda 2016 Asociación Iberoamericana para el Dereho Alimentario

The Impact Of International Agreements On European Union Food Law, Luis González Vaqué, Isabel Segura Roda

Luis González Vaqué

This paper discusses how international agreements affect the development of Food Law in both MemberStates and the EU itself. The relevance of this topic lies in the major structural changes currently affecting the whole agri-food system as a result of two conflicting trends which are more than just political or economic: on the one hand, the seemingly inevitable process of globalization, and on the other, the growing trend towards (re)localizing production, trade and consumption. 


States Vs. Fda, Catherine M. Sharkey 2016 NYU School of Law

States Vs. Fda, Catherine M. Sharkey

New York University Public Law and Legal Theory Working Papers

In the United States, food and drug safety is regulated in two ways: a stringent ex ante, national regime led by the Food and Drug Administration (“FDA”) and a robust ex post system of state-law enforcement. This federalist structure, operating on dual regulatory levels, sets the stage for synergy and for conflict.

Two recent high-profile preemption lawsuits showcase a novel dimension of the dual regulatory structure: the role of states as competing and/or complementary actors vis-à-vis the FDA in regulating food and drug safety. In Zogenix, Inc. v. Patrick, a federal district court enjoined the Massachusetts government from enacting ...


States Vs. Fda, Catherine M. Sharkey 2016 NYU School of Law

States Vs. Fda, Catherine M. Sharkey

New York University Law and Economics Working Papers

In the United States, food and drug safety is regulated in two ways: a stringent ex ante, national regime led by the Food and Drug Administration (“FDA”) and a robust ex post system of state-law enforcement. This federalist structure, operating on dual regulatory levels, sets the stage for synergy and for conflict.

Two recent high-profile preemption lawsuits showcase a novel dimension of the dual regulatory structure: the role of states as competing and/or complementary actors vis-à-vis the FDA in regulating food and drug safety. In Zogenix, Inc. v. Patrick, a federal district court enjoined the Massachusetts government from enacting ...


Reflexiones Con Respecto A La Política De La Dea , Y, De Antinarcóticos En América Latina®, Daniel Fernando Gomez Tamayo 2016 Selected Works

Reflexiones Con Respecto A La Política De La Dea , Y, De Antinarcóticos En América Latina®, Daniel Fernando Gomez Tamayo

Daniel Fernando Gómez Tamayo

Reflexiones con respecto a la ley 1696 de 2013 y  la  sentencia C 221 de 1991 que despenalizó la dosis personal, pues a juicio de estudiosos de las políticas públicas frente a las drogas consideran que el estado y las mafias deben conciliar sus intereses;  independiente del debate de la legalización o no;  es claro que  se debe realizar campañas educativas y preventivas para evitar que los adolescentes caigan en el flagelo de la drogadicción como consecuencia de la guerra. 


Reflexiones Con Respecto A La Política De La Dea , Y, De Antinarcóticos En América Latina®, Daniel Fernando Gomez Tamayo 2016 Selected Works

Reflexiones Con Respecto A La Política De La Dea , Y, De Antinarcóticos En América Latina®, Daniel Fernando Gomez Tamayo

Daniel Fernando Gómez Tamayo

Reflexiones con respecto: al negocio redondo de  la DEA en Colombia y en México, la ley 599 de 2000  que penalizó la producción: de la cocaína, de la marihuana y del opio que son útiles en medicina y en la odontología. Respetando opiniones distintas, el mercado de estupefacientes no se creo por la  sentencia C- 221 de 1991 que  despenalizó la dosis personal; sino por leyes de la oferta y la demanda. ¿Por qué razón el gobierno nacional de Colombia y el gobierno de México no cambian esa guerra absurda impuesta por los Estados Unidos contra los productores? ¿no será ...


Digital Commons powered by bepress